Therapeutic Strategies of Denosumab Sequential Therapy: A Four-Armed Randomized Controlled Trial.
Sign Up to like & getrecommendations! Published in 2025 at "Clinical pharmacology and therapeutics"
DOI: 10.1002/cpt.70088
Abstract: After denosumab discontinuation, the rebound effect can lead to rapid bone loss and increased fracture risk. Identifying effective sequential therapies after denosumab discontinuation is crucial to mitigate these risks. We conducted the Denosumab Sequential Therapy… read more here.
Keywords: zoledronate; trial; group; zoledronate group ... See more keywords